HeartBeam Launches Pilot Study for On-Demand 12-Lead ECG Patch to Detect Ischemia

HeartBeam Inc. has initiated a pilot study for its novel patch that can generate an on-demand 12-lead ECG, potentially transforming ischemia detection and disrupting the cardiac monitoring market.

Philly Metrowire Staff
Healthcare
HeartBeam Launches Pilot Study for On-Demand 12-Lead ECG Patch to Detect Ischemia

HeartBeam Inc. (NASDAQ: BEAT) announced the launch of a pilot study focused on evaluating its proprietary on-demand 12-lead ECG patch in detecting coronary artery disease and ischemia. This development addresses a critical gap in ambulatory monitoring, as current patch-based devices cannot detect ischemia or provide clinical-grade insights over extended periods.

Coronary artery disease remains a leading cause of death worldwide, often progressing silently until a major cardiac event. The ability to detect ischemia early through a non-invasive, wearable patch could significantly improve patient outcomes. HeartBeam's patch is designed to generate a 12-lead ECG on demand, similar to what is obtained in a clinical setting, but in a portable form factor. This capability has the potential to disrupt the $2 billion long-term continuous monitor and mobile cardiac telemetry (MCT) markets.

According to HeartBeam CEO Robert Eno, “Ischemia detection has not been possible on patch-based ambulatory monitors, and they do not provide clinical-grade insights over an extended period of time. The HeartBeam patch is designed to change that. A device capable of generating an on-demand…”. The pilot study marks a significant step in the development of the patch, which could offer healthcare providers a faster and more accessible way to identify high-risk patients earlier.

The implications of this study are far-reaching. If successful, the HeartBeam patch could enable continuous monitoring for patients with known or suspected coronary artery disease, allowing for timely intervention and potentially reducing the incidence of heart attacks and other cardiac events. The technology also aligns with the growing trend toward remote patient monitoring and telehealth, offering a practical solution for patients who cannot easily access traditional ECG testing.

For more information about HeartBeam and its latest news, visit the company’s newsroom at https://nnw.fm/BEAT. NetworkNewsWire, a financial news and content distribution platform, provided this information and is part of the Dynamic Brand Portfolio @IBN. For more details, visit https://www.NetworkNewsWire.com. Please see full terms of use and disclaimers at https://www.NetworkNewsWire.com/Disclaimer.

Blockchain Registration

QR Code for Blockchain Registration